Harwant Singh*
Department of Spine and Joint Clinic, Pantai, Hospital, Kualalumpur, Malaysia
*Corresponding Author: Harwant Singh, Department of Spine and Joint Clinic, Pantai, Hospital, Kualalumpur, Malaysia.
Received: April 11, 2022; Published: May 20, 2022
The COVID pandemic is coming to an end; and cross border travel for surgery will resume. The cross border surgical treatments seen in two main forms; medical tourism and outreach/teaching care. Both these cross border surgical treatments have inherent risks, such as increased costs, unexpected outcomes, and recovery from surgical injury and malpractice. The best method to minimise these risks are to have processes in place which protect the patient and the surgeon. These include a high standard of ethics, a patients’ charter, an appraisal of the risks inherent in both types of cross border surgical treatment, an informed consent of a high standard and a statement of continuity of care so that ambiguity is reduced. Also, with the advent of pandemic viruses such as covid 19, assurances that such infections are not inadvertently spread by poor screening procedures of surgeons who travel, or patients who travel. With the adoption of these suggestions it is hoped that the process of cross border surgical treatments can be formalised safely; with a very high standard of care for the patient and sufficient protection for the surgeon providing the care.
Keywords: Cross Border; Surgical Treatment; COVID 19; World
Citation: Harwant Singh. “Cross Border Surgical Treatment: Issues to Consider when Resumption of Travel Begins in a Post COVID 19 World". Acta Scientific Orthopaedics 5.6 (2022): 75-81.
Copyright: © 2022 Harwant Singh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.